Unknown

Dataset Information

0

Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis.


ABSTRACT: Immune checkpoint inhibitors (CPIs) are a relatively newly licenced cancer treatment, which make a once previously untreatable disease now amenable to a potential cure. Combination regimens of anti-CTLA4 and anti-PD-1 show enhanced efficacy but are prone to off-target immune-mediated tissue injury, particularly at the barrier surfaces. To probe the impact of immune checkpoints on intestinal homoeostasis, mice are challenged with anti-CTLA4 and anti-PD-1 immunotherapy and manipulation of the intestinal microbiota. The immune profile of the colon of these mice with CPI-colitis is analysed using bulk RNA sequencing, single-cell RNA sequencing and flow cytometry. CPI-colitis in mice is dependent on the composition of the intestinal microbiota and by the induction of lymphocytes expressing interferon-γ (IFNγ), cytotoxicity molecules and other pro-inflammatory cytokines/chemokines. This pre-clinical model of CPI-colitis could be attenuated following blockade of the IL23/IFNγ axis. Therapeutic targeting of IFNγ-producing lymphocytes or regulatory networks, may hold the key to reversing CPI-colitis.

SUBMITTER: Lo JW 

PROVIDER: S-EPMC10593820 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


Immune checkpoint inhibitors (CPIs) are a relatively newly licenced cancer treatment, which make a once previously untreatable disease now amenable to a potential cure. Combination regimens of anti-CTLA4 and anti-PD-1 show enhanced efficacy but are prone to off-target immune-mediated tissue injury, particularly at the barrier surfaces. To probe the impact of immune checkpoints on intestinal homoeostasis, mice are challenged with anti-CTLA4 and anti-PD-1 immunotherapy and manipulation of the inte  ...[more]

Similar Datasets

| PRJEB65719 | ENA
2024-11-27 | GSE207884 | GEO
| S-EPMC8586074 | biostudies-literature
| S-EPMC8165319 | biostudies-literature
2023-08-22 | E-MTAB-12872 | biostudies-arrayexpress
| PRJNA857579 | ENA
| S-EPMC10966072 | biostudies-literature
| S-EPMC10246037 | biostudies-literature
| S-EPMC8724248 | biostudies-literature
| S-EPMC10539391 | biostudies-literature